Andrew R. Robbins - 22 Jun 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director
Signature
/s/ Andrew R. Robbins by Georgia Erbez, Attorney-in-Fact
Issuer symbol
HARP
Transactions as of
22 Jun 2022
Transactions value $
$0
Form type
4
Date filed
24 Jun 2022, 18:49
Previous filing
27 Jan 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +10.2K $0.00 10.2K 22 Jun 2022 Common Stock 10.2K $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.